This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy.
Leukemia & lymphoma · 2020
Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing.
Blood · 2020
Chronic Lymphocytic Leukemia Patients With Deletion 11q Have a Short Time to Requirement of First-Line Therapy, But Long Overall Survival: Results of a Population-Based Cohort in British Columbia, Canada.
Clinical lymphoma, myeloma & leukemia · 2017
Latest funding
- $1,548,954
Integrating Quantitative Imaging Methods and Genomic Biomarkers to Assess the Therapeutic Response of Cancers
CIHR · 2014 · Co-investigator
- $4,088,854
Exploring the relationship between the genome and the epigenome in cancers
CIHR · 2014 · Co-investigator
- $799,698
Identification of Genetic Factors for Familial Lymphoid Cancers
CIHR · 2013 · Co-investigator
8 publications.
Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy.
Straus D, Collins G, Walewski J, Zinzani PL, Grigg A, Sureda A, Illes A, Kim TM, Alekseev S, Specht L, Buccheri V, Younes A, Connors J, Forero-Torres A, Fenton K, Gautam A, Purevjal I, Liu R, Gallamini A
Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing.
Pararajalingam P, Coyle KM, Arthur SE, Thomas N, Alcaide M, Meissner B, Boyle M, Qureshi Q, Grande BM, Rushton C, Slack GW, Mungall AJ, Tam CS, Agarwal R, Dawson SJ, Lenz G, Balasubramanian S, Gascoyne RD, Steidl C, Connors J, Villa D, Audas TE, Marra MA, Johnson NA, Scott DW, Morin RD
Chronic Lymphocytic Leukemia Patients With Deletion 11q Have a Short Time to Requirement of First-Line Therapy, But Long Overall Survival: Results of a Population-Based Cohort in British Columbia, Canada.
Goy J, Gillan TL, Bruyere H, Huang SJT, Hrynchak M, Karsan A, Ramadan K, Connors J, Toze CL, Gerrie AS
A Canadian evidence-based guideline for the first-line treatment of follicular lymphoma: joint consensus of the Lymphoma Canada Scientific Advisory Board.
Kuruvilla J, Assouline S, Hodgson D, MacDonald D, Stewart D, Christofides A, Komolova M, Connors J
Cost-effectiveness of rituximab in follicular lymphoma.
Johnston KM, Bolbocean C, Connors J, Peacock S
Circos: an information aesthetic for comparative genomics.
Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, Jones SJ, Marra MA
Alemtuzumab in clinical practice: a British Columbia experience.
Hui D, Lam W, Toze C, Delorme M, Noble M, Klimo P, Sutherland J, Gill K, Connors J, Sehn L
Hepatic dysfunction during and after lymphoma chemotherapy in patients with hepatitis C.
Shah J, Yoshida EM, Connors J, Gill S
Integrating Quantitative Imaging Methods and Genomic Biomarkers to Assess the Therapeutic Response of Cancers
Principal investigators: Benard, Francois
Keywords: Quantitative Imaging
Exploring the relationship between the genome and the epigenome in cancers
Principal investigators: Marra, Marco A
Keywords: Biochemistry; Bioinformatics; Cancer; Cell Biology; Epigenomics; Functional Genomics; Genomics
Identification of Genetic Factors for Familial Lymphoid Cancers
Principal investigators: Brooks-Wilson, Angela R
Keywords: Exome Sequencing; Familial Cancer; Hodgkin Lymphoma; Lymphoid Cancer; Lymphoid Leukemia; Lymphoma; Multiple Myeloma; Next Generation Sequencing; Non-Hodgkin Lymphoma
Personalized Treatment of Lymphoid Cancer: British Columbia as Model Province
Principal investigators: Connors, Joseph
Keywords: Genomics; Health Economics; Lymphoma; Oncogenes; Sequencing
Centre for Epigenome Mapping Technologies
Principal investigators: Marra, Marco A; Hirst, Martin; Jones, Steven
Keywords: Aging; Bioinformatics; Cancer; Chromatin Marks; Dna Methylation; Epigenomics; Gene Regulation; Human Health; Multidisciplinary; Next Generation Sequencing
Genetic mechanisms underlying immune escape in malignant lymphomas
Principal investigators: Gascoyne, Randy D
Keywords: Immunology; Lymphoma Biology; Molecular Genetics
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- John Kuruvilla and David Hodgson: 15 shared papers
- Aly Karsan and Christian Steidl: 13 shared papers
- Christian Steidl and John Kuruvilla: 5 shared papers
- Aly Karsan and John Kuruvilla: 3 shared papers
- Aly Karsan and Joseph Connors: 1 shared paper
- Christian Steidl and Joseph Connors: 1 shared paper
- Joseph Connors and Stuart Peacock: 1 shared paper
- Joseph Connors and John Kuruvilla: 1 shared paper
- Joseph Connors and David Hodgson: 1 shared paper
- Stuart Peacock and David Hodgson: 1 shared paper
- Genome Sciences Centre
- Experimental Therapeutics
- Other
Co-authors at University of British Columbia, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.